Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.
The report details the trend, potential and market size of Ambrisentan Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ambrisentan Drugmarket, defines the market attractiveness level of Ambrisentan Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ambrisentan Drug industry, describes the types of Ambrisentan Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ambrisentan Drug market and the development prospects and opportunities of Ambrisentan Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ambrisentan Drug market in Chapter 13.
By Player:
Cipla Inc (India)
Par Pharmaceutical, Inc (United States)
Sigmapharm Laboratories, LLC (United States)
Gilead Sciences, Inc (United States)
Glaxo Smith Kline Limited (United Kingdom)
Mylan SAS (United States)
By Type:
5 mg Tablet
10 mg Tablet
By End-User:
Hospital
Drug store
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ambrisentan Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ambrisentan Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ambrisentan Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ambrisentan Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ambrisentan Drug Market Analysis and Outlook to 2022
-
7.1 Global Ambrisentan Drug Consumption (2017-2022)
-
7.2 United States Ambrisentan Drug Consumption (2017-2022)
-
7.3 Europe Ambrisentan Drug Consumption (2017-2022)
-
7.4 China Ambrisentan Drug Consumption (2017-2022)
-
7.5 Japan Ambrisentan Drug Consumption (2017-2022)
-
7.6 India Ambrisentan Drug Consumption (2017-2022)
-
7.7 South Korea Ambrisentan Drug Consumption (2017-2022)
8 Region and Country-wise Ambrisentan Drug Market Analysis and Outlook to 2028
-
8.1 Global Ambrisentan Drug Consumption Forecast (2022-2028)
-
8.2 United States Ambrisentan Drug Consumption Forecast (2022-2028)
-
8.3 Europe Ambrisentan Drug Consumption Forecast (2022-2028)
-
8.4 China Ambrisentan Drug Consumption Forecast (2022-2028)
-
8.5 Japan Ambrisentan Drug Consumption Forecast (2022-2028)
-
8.6 India Ambrisentan Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Ambrisentan Drug Consumption Forecast (2022-2028)
9 Global Ambrisentan Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Ambrisentan Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 5 mg Tablet Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 10 mg Tablet Consumption and Growth Rate (2017-2022)
-
9.2 Global Ambrisentan Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug store Consumption and Growth Rate (2017-2022)
10 Global Ambrisentan Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Ambrisentan Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 5 mg Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 10 mg Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ambrisentan Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug store Consumption Forecast and Growth Rate (2022-2028)
11 Global Ambrisentan Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ambrisentan Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ambrisentan Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ambrisentan Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ambrisentan Drug Market Competitive Analysis
-
14.1 Cipla Inc (India)
-
14.1.1 Cipla Inc (India) Company Details
-
14.1.2 Cipla Inc (India) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Cipla Inc (India) Ambrisentan Drug Product and Service
-
14.2 Par Pharmaceutical, Inc (United States)
-
14.2.1 Par Pharmaceutical, Inc (United States) Company Details
-
14.2.2 Par Pharmaceutical, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Par Pharmaceutical, Inc (United States) Ambrisentan Drug Product and Service
-
14.3 Sigmapharm Laboratories, LLC (United States)
-
14.3.1 Sigmapharm Laboratories, LLC (United States) Company Details
-
14.3.2 Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Product and Service
-
14.4 Gilead Sciences, Inc (United States)
-
14.4.1 Gilead Sciences, Inc (United States) Company Details
-
14.4.2 Gilead Sciences, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Gilead Sciences, Inc (United States) Ambrisentan Drug Product and Service
-
14.5 Glaxo Smith Kline Limited (United Kingdom)
-
14.5.1 Glaxo Smith Kline Limited (United Kingdom) Company Details
-
14.5.2 Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Product and Service
-
14.6 Mylan SAS (United States)
-
14.6.1 Mylan SAS (United States) Company Details
-
14.6.2 Mylan SAS (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mylan SAS (United States) Ambrisentan Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ambrisentan Drug
-
Figure Ambrisentan Drug Picture
-
Table Global Ambrisentan Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ambrisentan Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ambrisentan Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ambrisentan Drug Consumption by Country (2017-2022)
-
Figure United States Ambrisentan Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Ambrisentan Drug Consumption and Growth Rate (2017-2022)
-
Figure China Ambrisentan Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Ambrisentan Drug Consumption and Growth Rate (2017-2022)
-
Figure India Ambrisentan Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ambrisentan Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Ambrisentan Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5 mg Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global 10 mg Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drug store Consumption and Growth Rate (2017-2022)
-
Figure Global 5 mg Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 10 mg Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug store Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ambrisentan Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ambrisentan Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Cipla Inc (India) (Foundation Year, Company Profile and etc.)
-
Table Cipla Inc (India) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Inc (India) Ambrisentan Drug Product and Service
-
Table Par Pharmaceutical, Inc (United States) (Foundation Year, Company Profile and etc.)
-
Table Par Pharmaceutical, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Par Pharmaceutical, Inc (United States) Ambrisentan Drug Product and Service
-
Table Sigmapharm Laboratories, LLC (United States) (Foundation Year, Company Profile and etc.)
-
Table Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Product and Service
-
Table Gilead Sciences, Inc (United States) (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences, Inc (United States) Ambrisentan Drug Product and Service
-
Table Glaxo Smith Kline Limited (United Kingdom) (Foundation Year, Company Profile and etc.)
-
Table Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Product and Service
-
Table Mylan SAS (United States) (Foundation Year, Company Profile and etc.)
-
Table Mylan SAS (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan SAS (United States) Ambrisentan Drug Product and Service
-
